Search results
Will GSK Stock Rebound To Its 2022 Highs Of $47?
Forbes· 3 days agoGSK plc stock (NYSE: GSK) trades at $38 per share, about 20% below its peak level of over $47 seen in April 2022.
Biotech Stock Roundup: GSK, CVAC Revise Agreement, Updates From MRNA, RNAC & More
Zacks via Yahoo Finance UK· 4 days agoIt was a regular week for the biotech sector with quite a few important pipeline and regulatory...
Should We Be Delighted With GSK plc's (LON:GSK) ROE Of 36%?
Simply Wall St. via Yahoo Finance UK· 4 days agoWhile some investors are already well versed in financial metrics (hat tip), this article is for...
US Inks Vaccine Deal With Moderna as Bird Flu Threat Looms
Bloomberg via Yahoo Finance UK· 6 days ago(Bloomberg) -- Moderna Inc. secured nearly $200 million from the US government to speed development...